Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome.

ABSTRACT:

SUBMITTER: Yamato G

PROVIDER: S-EPMC8102190 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Two Novel <i>GATA1</i> Mutations in Transient Abnormal Myelopoiesis of Thai Neonates with Down Syndrome.

Project description: Not available

| S-EPMC6824893 | biostudies-literature

Affymetrix SNP array data for xenografted transient abnormal myelopoiesis samples

Project description:Transient abnormal myelopoiesis (TAM) is a clonal pre-leukemic disorder that progresses to myeloid leukemia of Down syndrome (ML-DS) through the accumulation of genetic alterations. To investigate the mechanism of leukemogenesis in this disorder, a xenograft model of TAM was established using NOD/Shi-scid, IL-2Rγnull mice. In serial transplantations, engrafted TAM-derived cells showed the emergence of divergent subclones with another GATA1 mutation and various CNAs, including a 16q deletion and 1q gain, which are clinically associated with ML-DS. These results suggest that genetically heterogeneous subclones with varying leukemia-initiating potential already exist in the neonatal TAM phase, and ML-DS may develop from a pool of such minor clones through clonal selection. Affymetrix SNP arrays were performed according to the manufacturer's directions on DNA extracted from murine bone marrow (hCD45 sorted) or human peripheral blood samples. Copy number analysis of Affymetrix 500K SNP arrays was performed for xenografted TAM samples of 3 patients. There are also 3 samples from TAM patients in remission, which were used as references for copy number inference.

2013-03-01 | E-GEOD-44739 | biostudies-arrayexpress

Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome.

Project description: Not available

| S-EPMC310710 | biostudies-literature

Affymetrix SNP array data for xenografted transient abnormal myelopoiesis samples

2013-03-01 | GSE44739 | GEO

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.

Project description: Not available

| S-EPMC4047213 | biostudies-literature

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.

Project description: Not available

| S-EPMC7558799 | biostudies-literature

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.

Project description: Not available

| S-EPMC2265448 | biostudies-literature

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia

Project description:Transient leukemia (TL) is evident in 5-10% of all neonates with Down syndrome (DS) and associated with N-terminal truncating GATA1-mutations (GATA1s). Here we analyzed the effect of on gene expression upon ectopic expression of Gata1s or Gata1, while simultaneously knocking down endogenous GATA1, in wild-type CD34+-hematopoietic stem and progenitor cells during myeloid differentiation. Ectopic expression of Gata1s, but not Gata1, in wild-type CD34+-hematopoietic stem and progenitor cells induced hyperproliferation of eosinophil promyelocytes in vitro. While GATA1s retained the function of GATA1 to induce eosinophil genes by occupying their promoter regions, GATA1s was impaired in its ability to repress oncogenic MYC and the pro-proliferative E2F transcription network.

2014-03-28 | GSE56332 | GEO

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia

2014-03-28 | E-GEOD-56332 | biostudies-arrayexpress

Myeloid leukemia in Down syndrome.

Project description: Not available

| S-EPMC3243928 | biostudies-literature